Contact Us

Phenylpropanolamine PPA
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

State where drug was ingested:

What product(s) was/were used containing PPA?

Was the injury a stroke/brain hemorrhage?

What date did stroke or hemorrhage occur?

If yes, what type of stroke/brain hemorrhage was suffered?

If you checked Ischemic, did injured party have Atrial Fibrillation?

How many days after using the PPA product did injured party suffer the stroke/hemorrhage?

How often was this medication used and when was it last used?

Does injured party still have this medication?

What additional medications were you taking at the time?

Have you taken the diet drug Meridia?

Please describe any residual damages resulting from stroke (paralysis, slurred speech, memory loss):

If stroke was suffered, has any doctor given his/her opinion as to the cause of the stroke?

If injured party did NOT have a stroke, what injuries were suffered as a result of PPA?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Woman Sues Drug Maker, Pharmacy

Sep 8, 2003 | The Greenville News.

A Greenville woman who says she suffered a stroke from taking cold medicine five years ago filed a lawsuit Monday against the drug's manufacturer and the pharmacy that sold it to her.

Sarah Taylor filed the suit Monday in the Greenville County Court of Common Pleas against GlaxoSmithKline Consumer Healthcare and CVS Pharmacy, Inc.

Officials from both GlaxoSmithKline and CVS declined to comment on the lawsuit.

The suit focuses on the drug Phenylpropanolamine, also known as PPA.The lawsuit says that Taylor bought BC Cold Powder and Contac 12-Hour Cold Capsules from CVS in the fall of 1998.

It alleges that she suffered a hemorrhagic stroke shortly afterward and is permanently disabled. It alleges that CVS failed to remove products containing PPA without warning customers about the risk of hermorrhagic stroke associated with its use.

The lawsuit alleges that for the last 30 years, the over-the-counter pharmaceutical industry has been aware, or should have been aware of reports associating PPA products with hemorrhagic stroke.

As of November 2000, labels on the products containing PPA never contained a warning about the risk of stroke, the suit alleges.

The suit accuses the defendants of negligence, failure to warn, unfair trade practices and fraud.

The suit asks a jury for general damages, medical expenses, loss of earnings, compensatory damages, punitive damages and attorneys' fees.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo